Dr. Lindhardt

Biography

Dr. Lindhardt is chief scientific officer, a position held since October 2017. He previously served as senior vice president of research and development from December 2013 to October 2017, as vice president, research and development from April 2011 to December 2013 and senior director of portfolio management and alliance manager from March 2010 to April 2011. From August 2008 to March 2010, Dr. Lindhardt served as the director of portfolio management for our predecessor Egalet A/S, and as a project manager from March 2008 to August 2008. Before joining Egalet A/S, Dr. Lindhardt served in management positions for Curalogic A/S and OSI Pharmaceuticals, and as a clinical pharmacologist for Ferring Pharmaceuticals and Novo Nordisk A/S. Dr. Lindhardt received an M.Sci. in Pharmaceutics, a Ph.D. in pharmaceutical development and pharmacology, each from the Royal Danish School of Pharmacy, and a Diploma of Business Excellence (DBE) from Columbia University and Copenhagen Business School.

Research Interest

Dr. Lindhardt is chief scientific officer, a position held since October 2017. He previously served as senior vice president of research and development from December 2013 to October 2017, as vice president, research and development from April 2011 to December 2013 and senior director of portfolio management and alliance manager from March 2010 to April 2011. From August 2008 to March 2010, Dr. Lindhardt served as the director of portfolio management for our predecessor Egalet A/S, and as a project manager from March 2008 to August 2008. Before joining Egalet A/S, Dr. Lindhardt served in management positions for Curalogic A/S and OSI Pharmaceuticals, and as a clinical pharmacologist for Ferring Pharmaceuticals and Novo Nordisk A/S. Dr. Lindhardt received an M.Sci. in Pharmaceutics, a Ph.D. in pharmaceutical development and pharmacology, each from the Royal Danish School of Pharmacy, and a Diploma of Business Excellence (DBE) from Columbia University and Copenhagen Business School.